madman
Super Moderator
* We discuss KYZATREX, a cutting-edge oral therapy that employs lymphatic absorption to preserve liver health and supports fertility, making it ideal for younger men. We also examine its ability to maintain hormone balance without the need for aromatase inhibitors
Shalin Shah is a distinguished leader in the field of metabolic health, specializing in testosterone replacement therapy. As the Chief Executive Officer of Marius Pharmaceuticals, he was instrumental in the development and FDA approval of KYZATREX® (testosterone undecanoate) CIII Capsules, an oral testosterone treatment for adult men with low or no testosterone levels due to certain medical conditions. With a global investment background, Shalin transitioned into healthcare with a mission to revolutionize the industry through metabolic health. His leadership at Marius Pharmaceuticals is marked by innovative strategies that prioritize consumer access and education.
We explore Shalin’s personal journey in this episode, including how it sparked a mission to redefine hormone health through innovative solutions like KYZATREX. Shalin sheds light on the misconceptions surrounding testosterone and the challenges in removing black box warnings. We discuss KYZATREX, a cutting-edge oral therapy that employs lymphatic absorption to preserve liver health and supports fertility, making it ideal for younger men. We also examine its ability to maintain hormone balance without the need for aromatase inhibitors. Join us as we navigate the future of testosterone treatments, breaking barriers in hormone replacement therapy and emphasizing the importance of education and awareness.
Topics discussed in this episode include:
* How Shalin's personal journey influenced his mission in testosterone replacement therapy.
* Why dismantling stigma around testosterone is crucial for hormone health advancement.
* How KYZATREX uses lymphatic absorption to prevent liver damage and support fertility.
* Why KYZATREX's design eliminates the need for aromatase inhibitors in therapy.
* Exploring KYZATREX's research on maintaining hormone balance and fertility.
* Misconceptions about testosterone and hormone replacement therapy.
* Why younger men find KYZATREX appealing due to its fertility-preserving benefits.
* Understanding KYZATREX's impact on normalizing luteinizing hormone and follicle-stimulating hormone levels.
* How KYZATREX offers a more balanced hormonal approach without raising estrogen levels.
* Exploring the significance of testosterone as a vital metabolic hormone.
* How testosterone deficiency relates to conditions like insulin sensitivity and muscle mass issues.
* Why “normal” testosterone ranges need re-evaluation for better diagnosis and treatment.
* How free testosterone and SHBG levels influence testosterone therapy outcomes
*.How ongoing research is exploring KYZATREX's impact on sperm levels and testicular volume.
Much higher than 13% when using injectable esterified T!
Hopefully she sees this!
Shalin Shah is a distinguished leader in the field of metabolic health, specializing in testosterone replacement therapy. As the Chief Executive Officer of Marius Pharmaceuticals, he was instrumental in the development and FDA approval of KYZATREX® (testosterone undecanoate) CIII Capsules, an oral testosterone treatment for adult men with low or no testosterone levels due to certain medical conditions. With a global investment background, Shalin transitioned into healthcare with a mission to revolutionize the industry through metabolic health. His leadership at Marius Pharmaceuticals is marked by innovative strategies that prioritize consumer access and education.
We explore Shalin’s personal journey in this episode, including how it sparked a mission to redefine hormone health through innovative solutions like KYZATREX. Shalin sheds light on the misconceptions surrounding testosterone and the challenges in removing black box warnings. We discuss KYZATREX, a cutting-edge oral therapy that employs lymphatic absorption to preserve liver health and supports fertility, making it ideal for younger men. We also examine its ability to maintain hormone balance without the need for aromatase inhibitors. Join us as we navigate the future of testosterone treatments, breaking barriers in hormone replacement therapy and emphasizing the importance of education and awareness.
Topics discussed in this episode include:
* How Shalin's personal journey influenced his mission in testosterone replacement therapy.
* Why dismantling stigma around testosterone is crucial for hormone health advancement.
* How KYZATREX uses lymphatic absorption to prevent liver damage and support fertility.
* Why KYZATREX's design eliminates the need for aromatase inhibitors in therapy.
* Exploring KYZATREX's research on maintaining hormone balance and fertility.
* Misconceptions about testosterone and hormone replacement therapy.
* Why younger men find KYZATREX appealing due to its fertility-preserving benefits.
* Understanding KYZATREX's impact on normalizing luteinizing hormone and follicle-stimulating hormone levels.
* How KYZATREX offers a more balanced hormonal approach without raising estrogen levels.
* Exploring the significance of testosterone as a vital metabolic hormone.
* How testosterone deficiency relates to conditions like insulin sensitivity and muscle mass issues.
* Why “normal” testosterone ranges need re-evaluation for better diagnosis and treatment.
* How free testosterone and SHBG levels influence testosterone therapy outcomes
*.How ongoing research is exploring KYZATREX's impact on sperm levels and testicular volume.
Much higher than 13% when using injectable esterified T!
Hopefully she sees this!
If you're considering testosterone replacement therapy, understanding its effects on testicular size is crucial. Learn why shrinkage occurs, the treatments available to mitigate this side effect, and why testicle size usually has minimal impact on your overall health. Urologist John Smith, MD, delves into these aspects to provide a comprehensive view.
2:50-4:40
healthcare.utah.edu
2:50-4:40

What Men Should Know About Testicular Shrinkage and Testosterone Therapy
Considering testosterone replacement therapy? Understand its impact on testicular size, treatment options for mitigating shrinkage, and why it's usually a minimal health concern.
- madman
- trt; testosterone; testicular atrophy; hcg
- Replies: 4
- Forum: Testosterone Side Effect Management
Principle investigator Dr. Irwin Goldstein of course!
Description of the study
This study is being conducted in an unblinded fashion because the primary endpoint is pharmacokinetic information, and all subjects will receive the same active drug at the same dosage. The primary objectives of this study are to assess the short-term safety and to investigate the pharmacokinetics of serum concentration of total testosterone with daily administration of one (1)...

An Open-Label Study of 50 Mg Oral Testosterone Undecanoat...
Découvrez les derniers essais cliniques, études de recherche et avancées médicales révolutionnaires grâce à notre plateforme complète et conviviale. Tro...
clinicaltrial.be
Description of the study
This study is being conducted in an unblinded fashion because the primary endpoint is pharmacokinetic information, and all subjects will receive the same active drug at the same dosage. The primary objectives of this study are to assess the short-term safety and to investigate the pharmacokinetics of serum concentration of total testosterone with daily administration of one (1)...
- madman
- hrt; hypogonadism/hssd; oral t therapy
- Replies: 3
- Forum: HRT in Women